New stock announcement | TYK MEDICINES-B (02410) priced at HK$12.1 per share, oversubscribed 2.29 times in public offering.
Tongyuan Kang Pharmaceutical-B (02410) announced the results of the placement, with a total of 47.88 million shares issued globally by the company.
TYK MEDICINES-B (02410) announced the distribution results, with a global offering of 47.88 million shares, of which 10% are allocated for public offering in Hong Kong and 90% for international offering. The final offering price is HK$12.1 per share, raising a net amount of approximately HK$506 million globally. Each board lot consists of 500 shares, and the shares are expected to commence trading on the Hong Kong Stock Exchange on Tuesday, August 20, 2024, at 9:00 am.
The public offering in Hong Kong was oversubscribed by 2.29 times, while the international offering was oversubscribed by 1.01 times.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


